Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma
J Natl Compr Canc Netw 2016 Jul 01;14(7)820-824, AP Fay, G de Velasco, TH Ho, EM Van Allen, B Murray, L Albiges, S Signoretti, AA Hakimi, ML Stanton, J Bellmunt, DF McDermott, MB Atkins, LA Garraway, DJ Kwiatkowski, TK ChoueiriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.